ProfileGDS4718 / 217967_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 52% 69% 99% 52% 78% 29% 52% 61% 75% 58% 67% 75% 53% 50% 54% 82% 69% 54% 46% 70% 64% 58% 70% 75% 66% 39% 77% 47% 61% 2% 43% 89% 61% 48% 72% 53% 37% 71% 59% 99% 65% 34% 87% 35% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6541552
GSM549102patient 115, normal, homogenized [OPG study]6.7534769
GSM549104patient 119, normal, homogenized [OPG study]12.410899
GSM549108patient 138, normal, homogenized [OPG study]5.656952
GSM549119patient 077, normal, homogenized [OPG study]7.5383278
GSM549133patient 032, cancer, homogenized [OPG study]4.45429
GSM549139patient 042, cancer, homogenized [OPG study]5.5856252
GSM549099patient 107, normal, homogenized [OPG study]6.1603861
GSM549109patient 139, normal, homogenized [OPG study]7.3230275
GSM549110patient 046, normal, homogenized [OPG study]5.9719558
GSM549114patient 063, normal, homogenized [OPG study]6.6346367
GSM549122patient 082, normal, homogenized [OPG study]7.2965575
GSM549134patient 033, cancer, homogenized [OPG study]5.6619153
GSM549136patient 036, cancer, homogenized [OPG study]5.4572550
GSM549140patient 044, cancer, homogenized [OPG study]5.7102254
GSM549111patient 047, normal, homogenized [OPG study]8.134282
GSM549113patient 057, normal, homogenized [OPG study]6.8058369
GSM549132patient 031, cancer, homogenized [OPG study]5.7565354
GSM549137patient 038, cancer, homogenized [OPG study]5.265446
GSM549142patient 047, cancer, homogenized [OPG study]6.8742970
GSM549100patient 110, normal, homogenized [OPG study]6.353264
GSM549107patient 135, normal, homogenized [OPG study]5.95758
GSM549115patient 068, normal, homogenized [OPG study]6.8637170
GSM549116patient 072, normal, homogenized [OPG study]7.3606275
GSM549120patient 078, normal, homogenized [OPG study]6.5659666
GSM549131patient 030, cancer, homogenized [OPG study]4.8708439
GSM549118patient 074, normal, homogenized [OPG study]7.5547277
GSM549129patient 027, cancer, homogenized [OPG study]5.3771947
GSM549123patient 088, normal, homogenized [OPG study]6.2288661
GSM549124patient 006, cancer, homogenized [OPG study]3.465712
GSM549126patient 015, cancer, homogenized [OPG study]5.1138643
GSM549128patient 025, cancer, homogenized [OPG study]9.0308489
GSM549103patient 117, normal, homogenized [OPG study]6.1764161
GSM549117patient 073, normal, homogenized [OPG study]5.3545848
GSM549138patient 041, cancer, homogenized [OPG study]7.0972872
GSM549141patient 045, cancer, homogenized [OPG study]5.6640253
GSM549130patient 028, cancer, homogenized [OPG study]4.8778637
GSM549101patient 111, normal, homogenized [OPG study]6.9181871
GSM549105patient 128, normal, homogenized [OPG study]6.0515459
GSM549106patient 134, normal, homogenized [OPG study]12.84399
GSM549112patient 048, normal, homogenized [OPG study]6.4746565
GSM549125patient 011, cancer, homogenized [OPG study]4.7215134
GSM549127patient 024, cancer, homogenized [OPG study]8.6750387
GSM549135patient 035, cancer, homogenized [OPG study]4.7026235